https://www.selleckchem.com/products/ps-1145.html
Treating tumor-bearing mice with Enoxacin significantly inhibited tumor growth in xenograft tumor model. Our results suggested that Enoxacin could be developed as a potential anti-tumor agent against prostate carcinoma. Our results suggested that Enoxacin could be developed as a potential anti-tumor agent against prostate carcinoma. The aim of this study is to comparatively examine the possibility of reducing the exposure dose to organs at risk, such as the hippocampus and lens, and improving the dose distribution of the planned target
Like
Comment
Share
